Company Overview
Snapshot
Founded in May 2010, Medivalve operates with 1–10 employees. The company is currently in the Pre-Funding stage. In September 2014, Medivalve successfully tested its new cardio device.
Business overview
Medivalve is a Health Tech & Life Sciences company developing acWire, a medical device designed to facilitate the accurate placement and alignment of medical devices within the cardiovascular system. This single-use, fully disposable guidewire utilizes shape-memory alloy technology to identify cardiovascular structures during interventional procedures, particularly transcatheter aortic-valve implantation, using existing fluoroscopic imaging methods. The company's product is in the clinical trial stage and serves the healthcare sector, specifically providers, in markets such as the United States and Europe.
Strategic signal
In September 2014, Medivalve successfully tested its new cardio device, acWire. This milestone indicates the company's progress in validating its medical technology, suggesting potential for advancement in cardiovascular diagnostic and interventional procedures. For investors, this signals a positive step in product development and clinical viability within the medical device market.
Log in to access full profile ›Company Intelligence Q&A
- What is Medivalve's primary product?
- Medivalve's primary product is acWire, a medical device intended to facilitate the accurate placement and alignment of medical devices in the cardiovascular system during diagnostic and interventional cardiovascular procedures.
- When was Medivalve founded?
- Medivalve was founded in May 2010.
- What is the current status of Medivalve's product development?
- Medivalve's product, acWire, is currently in the clinical trial stage. In January 1970, Medivalve Ltd. announced the initiation of post-market clinical evaluations for the acWire guidewire at Lenox Hill Hospital, as reported by Vascular Disease Management.
- What was a significant development for Medivalve in September 2014?
- In September 2014, Medivalve successfully tested its new cardio device, acWire.
- What markets does Medivalve target?
- Medivalve targets geomarkets including the United States and Europe for its medical devices.